U.S. Senator Sanders urges FDA to allow older versions of $375K drug
February 28, 2019 at 07:00 AM EST
U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost versions of a drug used to treat a rare neuromuscular disorder, according to a letter provided by his office to Reuters.